Skip to Content


Scientific Name(s): Cynara cardunculus L., Cynara scolymus L.
Common Name(s): Alcachofra, Extractum Cynarae aq. Siccum, Garden artichoke, Globe artichoke

Clinical Overview


Artichoke has been used for its antioxidant and GI soothing effects. It may also have moderately hypoglycemic and hypolipidemic properties; however, clinical information for any use is lacking.


A range of divided doses from 600 to 3,200 mg/day have been used in clinical trials.


Allergy to Asteraceae family plants (eg, daisy, chrysanthemum, marigold, Echinacea, ragweed); bile duct obstruction.


Artichoke heads are generally recognized as safe (GRAS) when used as food. Information is lacking for artichoke leaf extract; caution is warranted.


None well documented.

Adverse Reactions

Mild, transient, and infrequent adverse reactions generally limited to GI complaints. Allergic reactions and a case of hepatotoxicity have been reported.


Specific toxicological studies are limited. No toxicity was observed in vitro in a study of artichoke leaf extract on human umbilical endothelial cells and hamster ovary cells. Some genotoxicity was demonstrated in vitro on bone marrow cells at the highest dose administered.


The artichoke is a member of the daisy family. It is a perennial herb, widely cultivated in Mediterranean regions and adjoining parts of central Europe. This well-known plant grows to a height of approximately 2 m. It has a strong, erect stem, and its large, thistle-like leaves are lobed and gray-green. The edible flower bud is purple-green and enclosed by scales or bracts, and blooms from July to August. The plant should not be confused with the Jerusalem artichoke (Helianthus tuberosus).1, 2, 3, 4


The artichoke has been cultivated for thousands of years, with the Greek physician Dioscorides (circa AD 40-90) recommending the application of mashed roots on the body to sweeten offensive odors. The artichoke was used as food and medicine by ancient Egyptians, Greeks, and Romans (although the exact plant used has been disputed), and appeared in Europe in the 15th century. The botanical name is derived in part from the tradition of fertilizing the plant with ashes, and partly from the Greek skolymos, meaning "thistle" from the spines found on the bracts that enclose the flower heads forming the edible portion of the plant. The French have used artichoke juice as a liver tonic. The herb's abilities to break down fat and improve bile flow have been recognized. Artichoke has been used traditionally to treat a variety of conditions, including hepatic diseases, jaundice, dyspepsia, and chronic albuminuria. It has also been used as a diuretic and to manage postoperative anemia.1, 2, 3, 4


Nutritionally, the artichoke head contains fat, carbohydrates, and protein. It also contains fiber (inulin), calcium, phosphorus, potassium, folic acid, vitamin C, niacin, thiamine, trace minerals, and carotenoids. Artichoke is an ideal source for essential polyunsaturated fatty acids, containing stearic, palmitic, oleic, and linoleic (50%) acids. Artichoke seed oil composition has been described. Color and anthocyanin pigments in artichoke have been evaluated, and the identity of numerous enzymes, including oxidases, peroxidases, cynarase, and ascorbinase, have been reported.

Caffeic acid and its derivatives in artichoke have been widely studied. Hydroxymethylacrylic acid also has been isolated from artichoke.

Bitter sesquiterpene principles, such as grosheimin, cynaratriol, and cynaropicrin, have been reported from the plant, along with dehydrocynaropicrin, grosulfeimin and related guaianolides, and cynarolide. Flavonoids (0.1% to 1%), including flavone glycosides and rutin, are present in artichoke. Flavonoid glycosides apigenin, luteolin, cynaroside, scolimoside, cosmoside, quercetin, isorhamnetin, maritimein, and others also have been reported. Volatile oils of artichoke include beta-selinene and caryophyllene as major sesquiterpenes, eugenol, phenylacetaldehyde, and decanal.

Much of the pharmacologic activity of the leaves has been attributed to the presence of caffeoylquinic acid derivatives, mono- and di-caffeoylquinic acids, including chlorogenic, neochlorogenic, and cryptochlorogenic acids, luteolin, and cynarin.

High-performance liquid chromatography and other analytic methods have been described. The relative proportion of these compounds varies with the strain, age, and generation of the plant. For example, germinating seeds of the artichoke have higher cynarin content than the leaves, while cynaropicrin content is highest in young leaves, but not in the root of mature fruits and flowers.2, 5, 6, 7, 8, 9, 10, 11, 12, 13

Uses and Pharmacology

Antioxidant activity

Animal data

Antioxidant activity of artichoke leaf extract has been demonstrated in animal studies using both histology and oxidative stress biomarkers.14, 15, 16, 17, 18, 19 Protective effects have also been demonstrated against carbon tetrachloride-, lead-, and cadmium-induced toxicity.15, 20, 21

Clinical data

A small clinical study conducted among athletes found that pretreatment with artichoke leaf extract over 5 weeks increased their total antioxidant capacity over untreated participants following intensive exercise. Effects on performance were not reported.22


Animal data

Artichoke leaf extract protected hamster ovary cells against induced DNA lesions.19 Flavonoids and the polyphenol fractions possess chemopreventive effects as well, as seen with mouse skin cancers and human breast cancer and heptatoma cell lines.23, 24, 25

Clinical data

Research reveals no clinical trials using artichoke for the prevention or treatment of cancer.

Cholesterol-lowering effects

Animal data

Artichoke has been found to possess cholesterol-lowering effects in rodent studies. Leaf extracts were found to inhibit cholesterol biosynthesis. An increased excretion of fecal bile acids was also reported. Constituents cynaroside and aglycone luteolin were suggested to be mainly responsible for this effect, while chlorogenic, caffeic dicaffeoylquinic acids, and cynarin demonstrated little or no inhibitory effects.26, 27, 28

Clinical data

A Cochrane systematic review of clinical trials evaluating hypolipidemic effects of artichoke leaf extract has been published covering studies to mid-2012.29 Only 3 studies met inclusion criteria, and one of these was only available as an abstract. A modest positive effect on the lipid profile was shown with decreased total cholesterol. Two studies published since the review have reported reductions in total cholesterol, one demonstrating improved measures of endothelial function and the other reporting increased high-density lipoprotein (HDL) and decreased low-density lipoprotein (LDL). Participant numbers in these studies are small, with 18 in one and 92 in the other.30, 31 A small clinical study conducted among athletes designed to measure antioxidant effects found that pretreatment with artichoke leaf extract over 5 weeks decreased total cholesterol, but had no effect on HDL, LDL, or triglycerides.22 Similarly, a clinical study evaluating the hypotensive effects of artichoke leaf juice found no effect on the lipid profile, despite reducing systolic and diastolic pressure in patients with mild hypertension.32


Animal data

Limited studies in rats show a moderate hypoglycemic effect of artichoke flowering head extract.33, 34, 35

Clinical data

Limited clinical trials among overweight people have shown reduction in glycosylated hemoglobin and glycemia, with artichoke extracts alone and in combination with Phaseolus vulgaris (common bean).36, 37 A small clinical study conducted among athletes designed to measure antioxidant effects found that pretreatment with artichoke leaf extract over 5 weeks had no effect on serum glucose.22

As a component of medical nutrition therapy for patients with type 2 diabetes, the American Diabetes Association Standards of Care (2014) recommends higher quality dietary fat intake, as an alternative to decreased fat intake, by replacing saturated and/or trans fats with mono- and poly-unsaturated fatty acids in the diet. This Mediterranean-style approach to eating may improve glycemic control and cardiovascular disease risk factors (moderate quality evidence).57

GI effects

Animal data

Experiments in rodents with induced gastric-ulcers have shown dose-dependent increases in mucus production and reductions in gastric ulceration with both artichoke leaf and flower bud/head extract.38, 39

Clinical data

Very long chain inulin derived from artichoke root given to healthy adults (N = 32) increased the fecal bacterial count, acting as a probiotic.40 Probiotic-enriched artichokes have also been used as an enriched fiber-rich vegetable in constipation and to deliver probiotics.41, 42, 43 Post hoc analysis of an open-label study suggests artichoke leaf extract provided symptomatic relief in irritable bowel syndrome.44

Other uses

Alcohol hangover

A randomized trial evaluating artichoke as a cure for hangover found no significant difference compared with placebo among the 15 participants.45


Probiotic-enriched artichoke heads antagonized Escherichia coli and Clostridium spp. in an experiment.46 An extract from the fruit of artichoke inhibited Campylobacter species in vitro, while the leaf extracts showed antifungal activity.47 A small clinical study among patients with chronic hepatitis C found no effect on viral load or liver enzymes, despite being well tolerated.48


Guinea pig and rat ileum have demonstrated both contractile and relaxing effects from hydrophilic and lipophilic leaf extracts.49, 50


Cynaropicrin extracted from artichoke leaves suppressed nuclear factor kappa-B and prevented photoaging processes in a mouse skin model.51


Divided doses from 600 to 3,200 mg/day have been used in clinical trials.22, 29, 30, 31

Peak plasma levels of hydroxycinnamic acids at 0.5 hours have been reported, with a biphasic elimination profile. Bioavailability after cooking has also been demonstrated.4, 12

Pregnancy / Lactation

Artichoke heads are GRAS when used as food. Avoid dosages above those found in food because safety and efficacy are unproven. Information is lacking for artichoke leaf extracts; caution is warranted.52


Case reports are lacking. Artichoke leaf extract chelated lead in the gonads of rats20; however, no literature on chelation of other elements (eg, iron) is available.

Adverse Reactions

Most clinical studies with artichoke leaf extract report mild, transient, and infrequent adverse reactions generally limited to GI complaints, including bloating.29, 39, 48

A case report of hepatotoxicity associated with consumption of a French commercial artichoke product has been published; the manufacturers of the product acknowledge 2 other cases.53

Contact with artichoke and other Asteraceae family plants (daisy, chrysanthemum, marigold, Echinacea, and ragweed) has caused allergic reactions in sensitive individuals, with cynaropicrin and other sesquiterpene lactones possibly being the responsible chemical constituents. Dermatitis, rhinitis, asthma, and edema of the tongue have been reported rarely. Anaphylaxis to the inulin content has been reported,54 as well as nonallergic irritant contact dermatitis.55

The Expanded Commission E Monographs warn against the use of artichoke preparations in any bile duct pathology because of its choleretic properties.3


Specific toxicological studies are limited. No toxicity was observed in vitro in a study of artichoke leaf extract on human umbilical endothelial cells and hamster ovary cells.18, 19, 56 Median lethal doses in rats of 265 mg/kg (intraperitoneal) and 2,000 mg/kg (oral) have been estimated based on caffeoylquinic acid content.2 Some genotoxicity was demonstrated in vitro on bone marrow cells at the highest dose tested (2,000 mg/kg oral) and may be due to the flavonoid content of the leaf extract.52


1. Chevallier A. The Encyclopedia of Medicinal Plants. New York, NY: DK Publishing; 1996:96-97.
2. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. 2nd ed. Hoboken, NJ: Wiley-Interscience; 2003.
3. Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications; 2000.
4. Sonnante G, Pignone D, Hammer K. The domestication of artichoke and cardoon: from Roman times to the genomic age. Ann Bot. 2007;100(5):1095-1100.17611191
5. Schauenberg P, et al. Guide to Medicinal Plants. New Canaan, CT: Keats Publishing; 1977.
6. Wittemer SM, Ploch M, Windeck T, et al. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine. 2005;12(1-2):28-38.15693705
7. Nassar MI, Mohamed TK, Elshamy AI, El-Toumy SA, Abdel Lateef AM, Farrag AR. Chemical constituents and anti-ulcerogenic potential of the scales of Cynara scolymus (artichoke) heads. J Sci Food Agric. 2013;93(10):2494-2501.23576039
8. M Hassanein MM, El-Shami SM, El-Mallah MH. Investigation of lipids profiles of Nigella, lupin and artichoke seed oils to be used as healthy oils. J Oleo Sci. 2011;60(3):99-107.21343657
9. Farag MA, El-Ahmady SH, Elian FS, Wessjohann LA. Metabolomics driven analysis of artichoke leaf and its commercial products via UHPLC-q-TOF-MS and chemometrics. Phytochemistry. 2013;95:177-187.23902683
10. Negro D, Montesano V, Grieco S, et al. Polyphenol compounds in artichoke plant tissues and varieties. J Food Sci. 2012;77(2):C244-C252.22251096
11. Pandino G, Lombardo S, Mauromicale G. Mineral profile in globe artichoke as affected by genotype, head part and environment. J Sci Food Agric. 2011;91(2):302-308.20954162
12. Azzini E, Bugianesi R, Romano F, et al. Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (cultivar Violetto di Provenza) in human subjects: a pilot study. Br J Nutr. 2007;97(5):963-969.17408528
13. Abu-Reidah IM, Arraez-Roman D, Segura-Carretero A, Fernandez-Gutierrez A. Extensive characterisation of bioactive phenolic constituents from globe artichoke (Cynara scolymus L.) by HPLC-DAD-ESI-QTOF-MS. Food Chem. 2013;141(3):2269-2277.23870957
14. Magielse J, Verlaet A, Breynaert A, et al. Investigation of the in vivo antioxidative activity of Cynara scolymus (artichoke) leaf extract in the streptozotocin-induced diabetic rat. Mol Nutr Food Res. 2014;58(1):211-215.24254201
15. Mehmetçik G, Ozdemirler G, Koçak-Toker N, Cevikbaş U, Uysal M. Effect of pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress. Exp Toxicol Pathol. 2008;60(6):475-480.18583118
16. Juzyszyn Z, Czerny B, Pawlik A, Droździk M. The effect of artichoke (Cynara scolymus L.) extract on ROS generation in HUVEC cells. Phytother Res. 2008;22(9):1159-1161.18780283
17. Juzyszyn Z, Czerny B, Mysliwiec Z, Pawlik A, Droździk M. The effect of artichoke (Cynara scolymus L.) extract on respiratory chain system activity in rat liver mitochondria. Phytother Res. 2010;24(suppl 2):S123-S128.20091747
18. Juzyszyn Z, Czerny B, Pawlik A, Droździk M. Effect of artichoke extract (Cynara scolymus L.) on palmitic-1-14C acid oxidation in rats. Mol Nutr Food Res. 2008;52(5):589-594.18384091
19. Jacociunas LV, de Andrade HH, Lehmann M, et al. Protective activity of Cynara scolymus L. leaf extract against chemically induced complex genomic alterations in CHO cells. Phytomedicine. 2013;20(12):1131-1134.23830816
20. Gurel E, Caner M, Bayraktar L, Yilmazer N, Dogruman H, Demirci C. Effects of artichoke extract supplementation on gonads of cadmium-treated rats. Biol Trace Elem Res. 2007;119(1):51-59.17914219
21. Heidarian E, Rafieian-Kopaei M. Protective effect of artichoke (Cynara scolymus) leaf extract against lead toxicity in rat. Pharm Biol. 2013;51(9):1104-1109.23745593
22. Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielcka E, Horoszkiewicz-Hassan M. The influence of supplementation with artichoke (Cynara scolymus L.) extract on selected redox parameters in rowers. Int J Sport Nutr Exerc Metab. 2008;18(3):313-327.18562776
23. Miccadei S, Di Venere D, Cardinali A, et al. Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells. Nutr Cancer. 2008;60(2):276-283.18444161
24. Mileo AM, Di Venere D, Linsalata V, Fraioli R, Miccadei S. Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231. J Cell Physiol. 2012;227(9):3301-3309.22170094
25. Yasukawa K, Matsubara H, Sano Y. Inhibitory effect of the flowers of artichoke (Cynara cardunculus) on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin. J Nat Med. 2010;64(3):388-391.20225077
26. Küskü-Kiraz Z, Mehmetçik G, Dogru-Abbasoglu S, Uysal M. Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet. Phytother Res. 2010;24(4):565-570.19777605
27. Küçükgergin C, Aydin AF, Ozdemirler-Erata G, Mehmetçik G, Koçak-Toker N, Uysal M. Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol Trace Elem Res. 2010;135(1-3):264-274.19652921
28. Qiang Z, Lee SO, Ye Z, Wu X, Hendrich S. Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters. Phytother Res. 2012;26(7):1048-1052.22183827
29. Wider B, Pittler MH, Thompson-Coon J, Ernst E. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev. 2013;3:CD003335.23543518
30. Lupattelli G, Marchesi S, Lombardini R, et al. Artichoke juice improves endothelial function in hyperlipemia. Life Sci. 2004;76(7):775-782.15581909
31. Rondanelli M, Giacosa A, Opizzi A, et al. Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial. Int J Food Sci Nutr. 2013;64(1):7-15.22746542
32. Roghani-Dehkordi F, Kamkhah AF. Artichoke leaf juice contains antihypertensive effect in patients with mild hypertension. J Diet Suppl. 2009;6(4):328-341.22435514
33. Fantini N, Colombo G, Giori A, et al. Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats. Phytother Res. 2011;25(3):463-466.20737658
34. Loi B, Fantini N, Colombo G, et al. Reducing effect of a combination of Phaseolus vulgaris and Cynara scolymus extracts on food intake and glycemia in rats. Phytother Res. 2013;27(2):258-263.22565861
35. Zaru A, Maccioni P, Riva A, et al. Reducing effect of a combination of Phaseolus vulgaris and Cynara scolymus extracts on operant self-administration of a chocolate-flavoured beverage in rats. Phytother Res. 2013;27(6):944-947.22899449
36. Rondanelli M, Opizzi A, Faliva M, et al. Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from Cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial. Phytother Res. 2014;28(1):33-41.23440660
37. Rondanelli M, Giacosa A, Orsini F, Opizzi A, Villani S. Appetite Control and Glycaemia Reduction in Overweight Subjects treated with a Combination of Two Highly Standardized Extracts from Phaseolus vulgaris and Cynara scolymus [published online February 10, 2011]. Phytother Res.21308825
38. Ishida K, Kojima R, Tsuboi M, Tsuda Y, Ito M. Effects of artichoke leaf extract on acute gastric mucosal injury in rats. Biol Pharm Bull. 2010;33(2):223-229.20118544
39. Costabile A, Kolida S, Klinder A, et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr. 2010;104(7):1007-1017.20591206
40. Riezzo G, Orlando A, D'Attoma B, et al. Randomised clinical trial: efficacy of Lactobacillus paracasei–enriched artichokes in the treatment of patients with functional constipation—a double-blind, controlled, crossover study. Aliment Pharmacol Ther. 2012;35(4):441-450.22225544
41. Valerio F, Russo F, de Candia S, et al. Effects of probiotic Lactobacillus paracasei–enriched artichokes on constipated patients: a pilot study. J Clin Gastroenterol. 2010;44(suppl 1):S49-S53. 20495470
42. Marteau P. Therapy: Probiotic-enriched artichokes for abdominal discomfort. Nat Rev Gastroenterol Hepatol. 2012;9(5):251-252.22429956
43. Valerio F, De Bellis P, Lonigro SL, Morelli L, Visconti A, Lavermicocca P. In vitro and in vivo survival and transit tolerance of potentially probiotic strains carried by artichokes in the gastrointestinal tract. Appl Environ Microbiol. 2006;72(4):3042-3045.16598015
44. Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med. 2004;10(4):667-669.15353023
45. Pittler MH, Verster JC, Ernst E. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ. 2005;331(7531):1515-1518.16373736
46. Valerio F, de Candia S, Lonigro SL, et al. Role of the probiotic strain Lactobacillus paracasei LMGP22043 carried by artichokes in influencing faecal bacteria and biochemical parameters in human subjects. J Appl Microbiol. 2011;111(1):155-164.21447019
47. Zhu XF, Zhang HX, Lo R. Antifungal activity of Cynara scolymus L. extracts. Fitoterapia. 2005;76(1):108-111.15664472
48. Huber R, Müller M, Naumann J, Schenk T, Lüdtke R. Artichoke leave extract for chronic hepatitis C—a pilot study. Phytomedicine. 2009;16(9):801-804.
49. Emendörfer F, Emendörfer F, Bellato F, et al. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum. Biol Pharm Bull. 2005;28(5):902-904.15863902
50. Verspohl EJ, Ploch M, Windeck T, Klaes M, Schmidt T, Bauer K. Effect of two artichoke extracts (36_U and 36_EB) on rat ileum (with respect to bowel syndrome) and the peristaltic threshold. Phytomedicine. 2008;15(11):1002-1009.18424104
51. Tanaka YT, Tanaka K, Kojima H, et al. Cynaropicrin from Cynara scolymus L. suppresses photoaging of skin by inhibiting the transcription activity of nuclear factor-kappa B. Bioorg Med Chem Lett. 2013;23(2):518-523.23232059
52. Zan MA, Ferraz AB, Richter MF, et al. In vivo genotoxicity evaluation of an artichoke (Cynara scolymus L.) aqueous extract. J Food Sci. 2013;78(2):T367-T371.23330610
53. Sinayoko L, Mennecier D, El Jahir Y, et al. Acute hepatic injury secondary to ingestion of artichoke extracts [in French]. Hepanephrol. Gastroenterol Clin Biol. 2007;31(11):1039-1040.18166904
54. Franck P, Moneret-Vautrin DA, Morisset M, Kanny G, Mégret-Gabeaux ML, Olivier JL. Anaphylactic reaction to inulin: first identification of specific IgEs to an inulin protein compound. Int Arch Allergy Immunol. 2005;136(2):155-158.15650313
55. Pipili C, Cholongitas E, Ioannidou D. Phytocontact dermatitis caused by artichoke: an exceptionally rare case. Clin Exp Dermatol. 2009;34(4):534-535.19236426
56. Jacociunas LV, de Andrade HH, Lehmann M, et al. Artichoke induces genetic toxicity and decreases ethyl methanesulfonate-related DNA damage in Chinese hamster ovary cells. J Med Food. 2012;15(10):873-878.22892059
57. American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(suppl 1):S14-S80.24357209


This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.